Table 5 Comparison of androgen receptor expression between triple-negative and non-triple-negative breast cancer

From: Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer

Authors

Journal

AR expression in non-triple-negative breast cancer

AR expression in triple-negative breast cancer

Rakha et al24

Cancer (2007)

73% (1000/1370)

13% (36/282)

Niemeier et al29

Mod Pathol (2010)

93% (148/159)

10% (3/30)

Park et al30

Ann Oncol (2010)

80% (279/350)

35% (22/63)

Peters et al31

Cancer Res (2009)

83.3% (30/36)

16.7% (3/18)

  1. Abbreviation: AR, androgen receptor.
Back to article page